What is deuteration? Small Pharma’s Phase I Trial with SPL028 – Dr Carol Routledge

Dr. Carol Routledge, Chief Medical & Scientific Officer of Small Pharma, discusses more on the SPL028 Phase I healthy volunteer trial which will evaluate SPL028, our lead deuterated molecule, with supportive therapy for the treatment of Major Depressive Disorder.

About Small Pharma

We’re a biotechnology company researching and developing short-acting psychedelics with supportive therapy for mental health conditions.

Register for Company Updates

    Corporate Presentation

    Follow us: